Plus   Neg

KKR, Duke Rohlen Partner To Create Zeus Health - Quick Facts

Global investment firm KKR & Co. Inc. (KKR) and medical device veteran Duke Rohlen said Tuesday they have formed Zeus Health, a $100 million platform that will be focused on investing in and operating a portfolio of emerging medical device companies.

Zeus marks the continuation of a long-standing relationship between KKR and Rohlen. Throughout his career, Rohlen has led, grown and exited multiple medical device companies, including alongside KKR.

KKR noted that in 2016, it invested in Spirox, an ENT-focused medical device company led by Rohlen as CEO. Spirox was sold to Entellus Medical in 2017, and the combined business was sold to Stryker in 2018.

In 2017, KKR and Rohlen formed Ajax Health, a medical device platform company whose primary asset EpiX Therapeutics was sold to Medtronic in 2019.

KKR said its investment in Zeus Health is being funded through the firm's Health Care Strategic Growth Fund, which is focused on investing in high-growth health care-related companies.

KKR has invested about $14 billion across the healthcare sector since 2004.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Electric Co. filed a lawsuit against Siemens Energy AG, accusing the German power distribution company of stealing trade secrets for gas turbines. Siemens Energy allegedly used the information to get at least nine contracts to supply gas turbines to public utilities, and also covered up improper business gains. Following a court ruling, the U.S. Food and Drug Administration postponed the effective date for tobacco manufacturing companies to display new health warnings on cigarette packets and in advertisements, by additional 90 days. The warnings with color images is to promote greater public understanding of the negative health consequences of smoking. JPMorgan Chase & Co (JPM) reported strong results in the fourth quarter of 2020, with net profit up 42% largely driven by credit reserve releases of $2.9 billion. The Group said it ended the year with a CET1 ratio of 13.1% and capital above $200 billion, providing with meaningful capacity to further...
Follow RTT